Cancer Patients Europe - CPE

Startpagina
België
Brussels
Cancer Patients Europe - CPE

Cancer Patients Europe Vision is to reduce the burden of cancer on patients and survivors, their carers, the health care systems, and the society as a whole.

Cancer Patients Europe represents and empowers the voices of cancer patients and survivors.

10/06/2026

On 1-3 June 2026, AIM-SAFE project kicked off in Copenhagen!

Over three days of collaborative discussions, project partners worked together to shape immediate next steps in AIM-SAFE, funded by the Horizon Europe Research and Innovation Programme aiming at developing AI-powered tools to improve medication safety and support more informed treatment decisions, including patients living with cancer and older patients aged 65+ with multimorbidity and taking more than four medications.

CPE’s role is to ensure that patient voices remain a core aspect of the project. Through co-design activities, stakeholder engagement, and training on trustworthy AI in healthcare.

At CPE we are committed to making healthcare safer, more informed, and more sustainable for patients across Europe.

🔗 Learn more about the meeting: https://cancerpatientseurope.org/cancer-patients-europe-joined-aim-safe-kickoff-meeting-in-copenhagen/

🔗 Learn more about the project: https://cancerpatientseurope.org/aim-safe/

10/06/2026

📢 Join us in Brussels for the VOICE PM Networking Event on Meaningful Patient Involvement in Translational Personalised Medicine Research!

🗓️ Wednesday, 24 June 2026 from 14:00 to 18:00
📍 Rue de l'Industrie 24, 1040 Brussels

🗓️ Thursday, 25 June 2026 from 09:00 to 17:30
📍Skyline, Rue de Trèves 74, 1040 Brussels.

Bringing together patient organisations, researchers, clinicians, policymakers, regulatory bodies, industry representatives, and EP PerMed/ERA PerMed funded projects, this two-day event will explore how meaningful patient involvement can be embedded throughout the research and innovation pathway.

The programme includes project presentations, discussions on best practices and challenges in patient engagement, perspectives from regulatory and HTA stakeholders, and dedicated networking opportunities.

The second day will be integrated into the Cancer Patients Europe Annual Meeting, featuring a dedicated VOICE PM parallel session.

🔗 Register here: https://forms.office.com/Pages/ResponsePage.aspx?id=rgDBMPg_-UK5zSHKuq7DiyNm3dEbtP5IvAppdxcdAGlURUZEM0UwMDhIQzkxSzBVWkZHRVdaNU1YTSQlQCN0PWcu

🔗Read more about event here: https://cancerpatientseurope.org/voice-pm-networking-event/

09/06/2026

On 1 June 2026 CPE Senior Policy Officer Joséphine Mosset-Keane participated in the debate “Health at a Crossroads: Active Aging, Prevention & Demographic Resilience” co-hosted by MEP Gabriela Firea (S&D, Romania) at the European Parliament.

Our CPE Senior Policy Officer highlighted an important challenge in cancer care: patients can only benefit from precision medicine if they have access to the diagnostic tests needed to identify the right treatment.

Drawing on the findings of CPE’s ESR1 White Paper, she shared how many patients with metastatic breast cancer still face barriers to accessing biomarker testing and liquid biopsy, despite the availability of new targeted treatments. Too often, where a patient lives determines whether they can access the tests and treatments that could improve their outcomes and quality of life.

CPE called for better access to both innovative treatments and the diagnostic tests that make those treatments possible, as well as greater patient awareness of biomarker testing and precision medicine.

Because innovation only matters if patients can access it.

We thank MEP Gabriela Firea and all participants for this important discussion on the future of healthcare in Europe.

08/06/2026

Ni****ne addiction among young people is no longer a future risk - it is an urgent public health concern that demands action now.

Cancer Patients Europe is proud to co-author a joint open letter alongside European Network for Smoking and To***co and European and international health organisations, calling for stronger and more coherent EU action to protect youth from all forms of ni****ne addiction.

As new ni****ne products continue to evolve and target younger audiences, prevention, regulation, and youth protection must keep pace with today’s reality. Protecting the next generation starts with addressing ni****ne addiction at its source.

We are also grateful to CPE members who endorsed this important initiative and continue to stand with us in advocating for a tobacco-free generation.

🔗 Read the Open Letter: https://ensp.network/health-organisations-urge-eu-action-on-youth-ni****ne-addiction/

🔗 Discover the toolkit and join the movement toward a healthier, ni****ne-free future: https://ensp.network/social-media-toolkit-working-toward-a-tobacco-ni****ne-free-generation/

****neFreeFuture ***coFreeGeneration

08/06/2026

📢Register now for CPE Annual Meeting 2026

Our three-day flagship event will take place in Brussels on 24–26 June 2026, under the theme "Protecting and Improving Europe’s Cancer Care Model in a Changing World."

🗓️ Event Overview:
🔹 24 June: Political Engagement at the European Committee of the Regions
🔹 25 June: CPE Annual Conference 2026
🔹 26 June: CPE Annual General Assembly (CPE Members only)

Register now: https://lnkd.in/epwYJJqP

🔗 Help ensure Europe’s cancer care model delivers for everyone, everywhere. Discover more about our Annual Meeting: https://lnkd.in/gmeQvBSM

05/06/2026

🌍 Another impactful day at the !

Yesterday, Francisco Rodríguez Lozano, our Chair of the Board, welcomed MEP Nicholas Papandreou at the CPE stand at the ELPA Prevention Village. His visit highlighted the importance of prevention, early detection, and patient-centred cancer care across Europe.

We're proud to be here alongside European Liver Patients' Association, SOS hépatites Alsace-Lorraine, Federación Española del Hígado - FEH, International Diabetes Federation Europe, and Liver4Life, under the patronage of the European Parliament.

⏳ Today is your last chance to visit the Village and take advantage of the free screening opportunities availale on-site.

📍 Esplanade, European Parliament, Brussels
📅 Last day: 5 June 2026

📢 Stop by, get screened, and join us in advancing a more preventive, equitable, and human-centred approach to healthcare.

03/06/2026

On 8 May 2026, CPE hosted “The Price of Access: MFN Drug Pricing – What Could It Mean for Patient Access in Europe?” as part of our 2026 Webinar Series.

With US drug pricing policy increasingly affecting whether and when new cancer treatments reach European patients, CPE brought together policymakers, health economists, industry representatives, and patient advocates to unpack its real-world consequences.

Key takeaways from the discussion:
🔹 New cancer medicines can take 18 months or longer to reach patients in smaller countries after European approval;
🔹 Pricing decisions in one country ripple across borders through international reference pricing, widening inequalities in access to therapies;
🔹 Europe must urgently shift from reactive responses to coordinated, proactive strategies;
🔹 R&D investment moving away from Europe threatens both current access and future innovation.

At CPE, we remain committed to ensuring patient voices are central to every policy decision that shapes access to care.

🎥 Missed it? Watch the full recording here: https://cancerpatientseurope.org/the-price-of-access/

📄 Want to go deeper? Our report is now available:https://cancerpatientseurope.org/wp-content/uploads/2026/05/CPE_MFN-Webinar-Report_FINAL.pdf

AstraZeneca Roche

29/05/2026

On 27 May 2026 CPE participated in the Business Breakfast: “Shaping the Future of Gender-Specific Health: A Policy and Innovation Dialogue” in Brussels organised by RPP Group in Brussels.

CPE Senior Policy Officer Josephine Mosset joined the panel discussion moderated by Kinga Wójtowicz on “Ensuring Gender-Specific Diagnosis and Care”, highlighting the importance of gender-specific diagnosis and equitable access to care across Europe, alongside Emily Phillips and Emma Larsson.

As momentum around women’s health continues to grow across Europe, these conversations are essential to closing persistent gender gaps in healthcare through innovation, policy and collaboration.

🤝 Thank you to the RPP Group for organising and fellow speakers for the insightful discussion.

29/05/2026

On 27 May 2026 CPE participated in the Business Breakfast: “Shaping the Future of Gender-Specific Health: A Policy and Innovation Dialogue” in Brussels organised by RPP Group.

CPE Senior Policy Officer Josephine Mosset joined the panel discussion moderated by Kinga Wójtowicz on “Ensuring Gender-Specific Diagnosis and Care”, highlighting the importance of gender-specific diagnosis and equitable access to care across Europe, alongside Emily Phillips and Emma Larsson.

As momentum around women’s health continues to grow across Europe, these conversations are essential to closing persistent gender gaps in healthcare through innovation, policy and collaboration.

🤝 Thank you to the RPP Group for organising and fellow speakers for the insightful discussion.

Adres

Rue De L’Industrie 24
Brussels
1000

Website

https://cancerpatientseurope.org/

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer Cancer Patients Europe - CPE nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.